
usd apr pm et
summari compani provid diagnost test inform servic physician hospit
manag care organ employ govern agenc
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
pm stock trade
star recommend
recent chang hold
strong buy target price
recent chang
highlight section stock
report updat accordingli
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
reduc target
reflect ep dgx
histor forward averag cut ep
estim
oper incom
drop driven declin
volum last two week march
includ test due social
distanc shelter place measur
expect near-term headwind net volum
declin counter
impact see aggress cut cost
salari benefit reduct well
furlough workforc
govern benefit far includ million
care act amount less
revenu help off-set expens
lost revenu suspens
medicar sequestr decemb
suspens pama price cut revis
opinion reflect view test
volum nearli enough off-set
reduct rest dgx busi /paig
risk assess reflect leadership posit
larg matur diagnost test industri
compani broad geograph servic area divers
balanc custom mix grow recognit
import signific diagnost test
think regulatori uncertainti creat risk
fiscal year end dec ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview lead independ clinic lab oper offer
broad rang clinic laboratori test servic use physician detect diagnosi
treatment diseas medic condit test rang routin blood cholesterol
test highli complex esoter test gene-bas test molecular diagnost test
end network princip laboratori throughout number smaller
rapid respons stat laboratori patient servic center along facil
mexico puerto rico england
process approxim million requisit physician test request
million routin test gener net sale gene-bas esoter test
gener net sale anatom patholog test servic account net sale
diagnost solut account remain net sale routin test measur import health
paramet function kidney heart liver thyroid organ esoter test
perform less frequent routin test and/or requir sophist equip materi
profession hands-on attent highli skill personnel result gener price
substanti higher routin test
corpor strategi one largest compani see matur market
limit growth potenti forese annual industri sale growth low-singl digit dgx strategi
last updat novemb two key focal point acceler growth drive oper
excel aim acceler growth accret strateg acquisit partnership
integr deliveri network idn provis broad access diagnost innov achiev
recognit consumer-friendli provid diagnost inform servic support popul
health initi key theme drive oper excel includ reduct denial
patienc concess standard autom digit custom experi
protect access medicar act pama reimburs test price cut
maximum clf clinic laboratori fee
schedul reimburs rate cut maximum amount
disproportion affect small lab financi pressur lab attract acquisit opportun
think opportunist lab acquisit key driver growth next
year organ growth could achiev increas number higher-pr esoter test offer
achiev higher test volum
competit landscap clinic lab industri highli competit fragment thousand
independ clinic lab physician offic lab hospital-bas lab largest provid
lab servic thu enjoy signific economi scale competitor main competitor
publicli trade laboratori corpor america lh
financi trend sale decreas billion repres five-year compound
annual growth rate compound-annual-growth-rate impact sustain pressur reimburs rate adjust
ep expand repres five-year compound-annual-growth-rate dgx debt level moder
net debt total capit leverag debt trailing-twelve-month ebitda
concern compani free cash flow million million
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli under-valued usd
neutral sinc march technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
outlook health care servic
sub-industri next year neg
recess concern
impact expect demand typic health care
servic declin significantli yoy
peopl stay home health care
system focu shift address
exampl comment late march
anesthesiolog busi experienc
signific declin elect surgeri
volum driven closur oper
suit facil yet
opportun exampl lab
test provid labcorp quest
relat test
long term even weak macroeconom
condit persist expect demand health
care servic remain rel steadi
compar industri
import health care consum prior
profit health care
servic compani pressur recent
year factor rise wage labor
legislative/regulatori initi
difficult determin rise unemploy
relat effect affect
pressur
believ long-term trend rise
health care spend
incentiv legisl regul
find way control cost health care
servic industri easi target
cost cut exampl initi lower
health care cost includ trump initi
chang payment model dialysi treatment
bipartisan effort tackl surpris bill
unclear chang dialysi
payment affect firm like
long run believ surpris bill
legisl like neg impact
physician outsourc group mednax
limit physician reimburs
struck individu mandat
associ afford act
howev court avoid determin
much remain valid believ
outcom remov possibl
worst-cas scenario health care servic
firm complet
gener benefit increas
insur coverag past sever year
elimin certain provis
could neg impact
industri earli suprem court
agre hear case decis
case like made
earliest believ suprem
court allow remain
minim impact health care
prior anticip
sub-industri ep growth
estim growth rate given
fluiditi volatil current
situat await earn commentari
updat ep expect health
march
declin composit index
 health servic index
gain vs increas
base index
five-year market price perform apr
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
analyst research note compani news
reimburs pressur ep vs exceed estim
lift ep estim net revenu grew
year-over-year billion despit loss sever large-volum
low-margin capit contract basi point impact volum
growth requisit volum growth acceler organ
revenu per requisit declin one competitor offer rate
said contract would unprofit fortun
non-renew contract expect insignific impact
top bottom line adjust oper incom million
reflect oper margin /kevin huang
et cfra maintain hold opinion share inc
rais price target base
ratio ep estim multipl
five-year averag forward price-to-earnings ratio expect sustain
reimburs pressur clinic laboratori compani ep vs
lower estim lift ep
ep net revenu rose
year-over-year billion affect increas requisit
volum declin revenu per requisit organ basi
requisit volum increas report volum growth aid
acquisit remind expect see million
industry-wid reimburs pressur although off-set
acceler volum growth work expand relationship
begin juli member prefer
pm et cfra lower opinion share hold
strong buy reduc target reflect
ep dgx histor forward averag cut
ep estim
oper incom drop driven declin
volum last two week march includ test
due social distanc shelter place measur expect near-term
headwind net volum declin counter impact
see aggress cut cost salari benefit reduct well
furlough workforc govern benefit far includ
million care act amount less revenu
help off-set expens lost revenu suspens medicar
sequestr decemb suspens pama price cut revis
opinion reflect view test volum nearli enough
off-set reduct rest dgx busi /paig meyer
et cfra lift opinion share
strong buy hold lift target price
base ratio ep premium dgx
histor forward averag maintain ep estim
estim announc launch coronaviru
test servic abl begin test soon march new
servic expect test specimen collect appropri health care
set hospit physician offic rather quest
diagnost patient servic center phlebotomi site believ rapid
global spread viru confirm presumpt case
 accord cdc translat greater need test
 strong posit provid /paig meyer
pm et cfra maintain hold opinion share
incorpor lift target price base
ratio ep estim reflect slight premium
peer narrow ep estim start
ep estim close ep vs
beat capit iq consensu estim driven
strong volum growth exclud acquisit expand
health plan network access partial off-set reimburs pressur
dgx adjust oper margin improv
due volum growth on-going product improv
expect approxim revenu growth despit signific
reimburs pressur relat protect access medicar act
also anticip rise wage expens due tighten labor market
pm et cfra maintain hold opinion share
incorpor maintain target price base
ratio ep estim multipl
slightli five-year averag forward price-to-earnings ratio reflect
industry-wid reimburs pressur ep vs beat
expect keep ep estim lift
ep estim share trade slightli today
compani provid full-year guidanc came light rel consensu
expect net revenu grew year-over-year billion
expect requisit volum grew organ off-set
partial declin revenu per requisit continu focu
deliv cost effici counter industri headwind sustain
reimburs pressur increas payer focu drive better valu
adjust oper margin improv
pm et cfra maintain hold opinion share inc
lift target price base ratio
ep estim multipl slightli
five-year averag forward price-to-earnings ratio reflect industry-wid
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
redistribut reproduct prohibit without prior written permiss copyright cfra
content includ rate credit-rel analys data valuat model softwar
applic output therefrom part thereof content may modifi
revers engin reproduc distribut form mean store
databas retriev system without prior written permiss cfra content shall
use unlaw unauthor purpos cfra third-parti provid
well director offic sharehold employe agent guarante
accuraci complet timeli avail content
past perform necessarili indic futur result
document may contain forward-look statement forecast forecast
reliabl indic futur perform
report intend constitut offer solicit buy sell
secur engag invest activ report inform purpos
recommend report made respect particular investor
type investor secur financi instrument strategi mention herein may
suitabl investor materi intend specif investor
take account investor particular invest object financi situat
need act recommend materi consid whether
suitabl particular circumst necessari seek profession advic
cfra may licens certain intellectu properti provid servic otherwis
busi relationship certain issuer secur subject cfra
research report includ exchange-trad invest whose invest object
substanti replic return proprietari index cfra case cfra
paid fee tie amount asset invest fund volum trade
activ fund invest fund may result cfra receiv compens
addit subscript fee compens servic render cfra
howev part cfra compens servic tie recommend
rate addit inform subject compani may avail upon request
cfra financi data provid global market intellig document contain
global industri classif standard gic develop and/or exclus
properti inc global market intellig gic servic mark
 global market intellig licens use cfra
disclaim notic
certain inform report provid global inc and/or affili
subsidiari collect global inform subject follow
disclaim notic copyright global market intellig affili
applic right reserv noth contain herein invest advic
refer particular invest secur credit rate observ
concern secur invest provid recommend buy
sell hold invest secur make invest decis may
contain inform obtain third parti includ rate credit rate
agenc reproduct distribut inform third parti content
form prohibit except prior written permiss global
relat third parti applic neither third parti provid guarante
accuraci complet timeli avail inform includ rate
respons error omiss neglig otherwis regardless
caus result obtain use inform content
includ rate credit rate statement opinion statement
fact recommend purchas hold sell secur address
suitabl secur suitabl secur invest purpos
reli invest advic
